[EFFECT] TRINITY BIOTECH PLC SEC Filing

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

EFFECT

Rhea-AI Filing Summary

Analyzing...

01/26/2026 - 12:15 AM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	January 23, 2026 4:00 P.M.

Form:

F-1

CIK:	0000888721
Company Name:	TRINITY BIOTECH PLC
File Number:	333-292753

Source: View Original Filing on SEC EDGAR

Trinity Biotech Plc

NASDAQ:TRIB

TRIB Rankings

#6122 Ranked by Market Cap

N/A Ranked by Dividends

TRIB Latest News

Dec 23, 2025

Trinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth Initiatives

Dec 23, 2025

Trinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests

Dec 15, 2025

Trinity Biotech Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances

Nov 18, 2025

Trinity Biotech Secures Major Regulatory Approval for Offshored and Outsourced Manufacturing of Its Market Leading Uni-Gold Rapid HIV Test, Further Accelerating Financial Performance Transformation

Nov 14, 2025

Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test

TRIB Latest SEC Filings

Jan 26, 2026

[SCHEDULE 13D/A] TRINITY BIOTECH PLC Amended Major Shareholder Report

Jan 23, 2026

[424B3] TRINITY BIOTECH PLC Prospectus Filed Pursuant to Rule 424(b)(3)

Jan 15, 2026

[F-1] TRINITY BIOTECH PLC Foreign Issuer IPO Registration

Dec 18, 2025

[6-K] TRINITY BIOTECH PLC Current Report (Foreign Issuer)

Nov 21, 2025

[6-K] TRINITY BIOTECH PLC Current Report (Foreign Issuer)

TRIB Stock Data

Market Cap 17.54M

Float 14.68M

Insiders Ownership 12.01%

Institutions Ownership 13.95%

Short Percent 7.12%

Industry Medical Devices

Sector Healthcare

Website Link

Country Ireland

City Bray